Benzinga's Top Pre-Market NASDAQ Losers

Pain Therapeutics PTIE dipped 32.25% to $6.26 in the pre-market session. Pfizer PFE and PTIE received a Complete Response Letter from the US Food and Drug Administration (FDA) on the resubmission to the new drug application (NDA) for REMOXY. Durect Corporation DRRX dropped 32.04% to $2.10 in the pre-market trading. DRRX's trailing-twelve-month ROE is -128.94%. Micron Technology Inc MU moved down 11.63% to $7.45 in the pre-market session. MU reported downbeat quarterly earnings and revenue. Oracle Corporation ORCL fell 3.66% to $31.27 in the pre-market session. ORCL reported an unexpected decline in hardware sales.